SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,431,601 | +12.0% | 20,889 | +1.6% | 0.09% | +7.0% |
| Q2 2023 | $3,955,053 | -7.4% | 20,550 | -2.6% | 0.09% | -17.3% |
| Q1 2023 | $4,273,332 | +196.9% | 21,106 | +88.5% | 0.10% | +153.7% |
| Q4 2022 | $1,439,183 | +12.5% | 11,199 | +19.8% | 0.04% | +7.9% |
| Q3 2022 | $1,279,000 | -25.8% | 9,348 | -4.1% | 0.04% | -30.9% |
| Q2 2022 | $1,724,000 | +62.5% | 9,744 | +32.3% | 0.06% | +66.7% |
| Q1 2022 | $1,061,000 | +15.3% | 7,365 | +23.8% | 0.03% | +10.0% |
| Q4 2021 | $920,000 | +8.7% | 5,951 | +19.4% | 0.03% | -11.8% |
| Q3 2021 | $846,000 | +25.5% | 4,985 | +16.7% | 0.03% | +17.2% |
| Q2 2021 | $674,000 | -75.2% | 4,272 | -78.2% | 0.03% | -76.0% |
| Q1 2021 | $2,722,000 | +180.0% | 19,599 | +253.3% | 0.12% | +278.1% |
| Q4 2020 | $972,000 | – | 5,547 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |